Gender differences in local and systemic reactions to inactivated influenza vaccine, established by a meta-analysis of fourteen independent studies
- PMID: 8641306
- DOI: 10.1007/BF01586187
Gender differences in local and systemic reactions to inactivated influenza vaccine, established by a meta-analysis of fourteen independent studies
Abstract
In order to determine whether there is a difference between genders in reported adverse reactions to inactivated influenza vaccine, a computerized database of serological studies was investigated. A standardized questionnaire was used to evaluate vaccine reactogenicity. A total of 1,800 vaccinees in 14 studies were analyzed separately for two age groups ( < 60 and > or = 60 years of age). Females reported significantly more local reactions than males. The pooled odds ratio for the outcome measure "any local reaction" was 0.32 (95% confidence interval, 0.26-0.40, significant) and 0.54 (95% Cl, 0.41-0.70, significant) for young and elderly adults, respectively. Similar results were obtained for the outcome measure "any systemic reaction." Previous exposure to influenza or influenza vaccine had no influence on reactogenicity. There were no gender differences in sero-responses. In conclusion, gender should be regarded as a predictor of reported reactions to influenza vaccine in both young and elderly adults and should be addressed in future study designs.
Similar articles
-
Reactogenicity and immunogenicity of an inactivated influenza vaccine administered by intramuscular or subcutaneous injection in elderly adults.Vaccine. 2006 Mar 20;24(13):2395-402. doi: 10.1016/j.vaccine.2005.11.057. Epub 2005 Dec 13. Vaccine. 2006. PMID: 16406171 Clinical Trial.
-
Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis.Vaccine. 2002 Jan 31;20(9-10):1340-53. doi: 10.1016/s0264-410x(01)00471-6. Vaccine. 2002. PMID: 11818152
-
Reactogenicity of two 2010 trivalent inactivated influenza vaccine formulations in adults.Vaccine. 2011 Oct 19;29(45):7920-4. doi: 10.1016/j.vaccine.2011.08.073. Epub 2011 Aug 22. Vaccine. 2011. PMID: 21864621 Clinical Trial.
-
[Immunogenicity of inacitivated quadrivalent influenza vaccine in adults aged 18-64 years: A systematic review and Meta-analysis].Zhonghua Liu Xing Bing Xue Za Zhi. 2018 Dec 10;39(12):1636-1641. doi: 10.3760/cma.j.issn.0254-6450.2018.12.019. Zhonghua Liu Xing Bing Xue Za Zhi. 2018. PMID: 30572392 Chinese.
-
Seasonal influenza vaccines.Curr Top Microbiol Immunol. 2009;333:43-82. doi: 10.1007/978-3-540-92165-3_3. Curr Top Microbiol Immunol. 2009. PMID: 19768400 Review.
Cited by
-
The Xs and Y of immune responses to viral vaccines.Lancet Infect Dis. 2010 May;10(5):338-49. doi: 10.1016/S1473-3099(10)70049-9. Lancet Infect Dis. 2010. PMID: 20417416 Free PMC article. Review.
-
Roadmap for Sex-Responsive Influenza and COVID-19 Vaccine Research in Older Adults.Front Aging. 2022 Feb 11;3:836642. doi: 10.3389/fragi.2022.836642. eCollection 2022. Front Aging. 2022. PMID: 35821800 Free PMC article. Review.
-
Sex and Gender Impact Immune Responses to Vaccines Among the Elderly.Physiology (Bethesda). 2015 Nov;30(6):408-16. doi: 10.1152/physiol.00035.2015. Physiology (Bethesda). 2015. PMID: 26525340 Free PMC article. Review.
-
Frequency of Adverse Events Following Q Fever Immunisation in Young Adults.Vaccines (Basel). 2018 Dec 13;6(4):83. doi: 10.3390/vaccines6040083. Vaccines (Basel). 2018. PMID: 30551615 Free PMC article.
-
Impact of COVID-19 on women and children and the need for a gendered approach in vaccine development.Hum Vaccin Immunother. 2020 Dec 1;16(12):2932-2937. doi: 10.1080/21645515.2020.1826249. Epub 2020 Nov 11. Hum Vaccin Immunother. 2020. PMID: 33175602 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical